[카테고리:] FAQ

PositivePositive results indicate that we found pathogenic or likely pathogenic variants matching the patient’s phenotypes. The identified variants are most likely to cause the patient’s symptoms and disease. InconclusiveInconclusive results indicate that we found a variant of uncertain significance (VUS) matching the patient’s phenotypes. It is unclear whether the identified variants are causing the patient’s…

Yes, medical professionals must explain the test results to the patient. Medical professionals must guide their patients through the treatment plan.The patient may request information about the test.

3billion will send an email notification as soon as the reports are ready. You can find your reports on the My Tests -> 3bilion ID’s Details -> Report of the portal.

For 3B-GENOME and 3B-EXOME, the reports will be delivered within 5 weeks of receiving the sample. It will take 2 weeks for 3B-VARIANT.

In accordance with the Genetic Testing Control Regulations, all samples will be discarded immediately after the reports are delivered.If you wish to have your samples returned, please inform a 3billion representative or contact support@3billion.io in advance.

In some cases, if there are problems with the sample or how it was collected, samples may not meet our quality requirements. As it will be difficult to get accurate, reliable results, we will request for a new sample. A 3billion representative will reach out and guide you through the necessary steps.

If there is no prior request, 3billion discards samples immediately after delivering the reports.

Go to the Resources page and click “Requisition Form”.

3billion provides a unique 3billion ID to identify each test. A 3billion ID is generated when you place an order on 3billion’s portal from the My Tests page.

Please note that we are unable to accept blood collected from patients with certain hematological conditions. Patients with hematologic malignancy: Blood samples from patients with hematologic malignancy contain cells with abnormal variants, which may affect the sensitivity and specificity of a test. Patients with a bone marrow transplant: Patients who have received homologous bone marrow…